Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'

Go back to Abbott (ABT) acquires Cardiovascular Systems (CSII) in 'brilliant move'

Cardiovascular Systems (CSII) PT Raised to $20 at Stifel

February 9, 2023 8:07 AM UTC

Stifel analyst Mathew Blackman raised the price target on Cardiovascular Systems (NASDAQ: CSII) to $20.00 (from $18.00) while maintaining a Hold rating.... More

Lake Street Capital Markets Downgrades Cardiovascular Systems (CSII) to Sell

February 9, 2023 7:43 AM UTC

Lake Street Capital Markets analyst Brooks O'neil downgraded Cardiovascular Systems (NASDAQ: CSII) from Hold to Sell.


For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.


Shares of Cardiovascular Systems closed at $13.31 yesterday.

... More

Abbott (ABT) to acquire Cardiovascular Systems (CSII) for $20/share

February 9, 2023 6:22 AM UTC

Abbott (NYSE: ABT) and Cardiovascular Systems, Inc. (NASDAQ: CSII), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.

CSI is a leader in devices for... More

Cardiovascular Systems (CSII) Misses Q2 EPS by 5c

February 9, 2023 4:50 AM UTC

Cardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.20), $0.05 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $61.5 million versus the consensus estimate of $63.06 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

... More